Top Story

Same-day integrated mental health services may improve time to diagnosis, treatment initiation

October 6, 2015

Integrating same-day mental health services into primary care may facilitate PTSD diagnosis and treatment initiation, according to study findings in Psychiatric Services.

To determine if same-day integrated mental health services increased diagnosis and treatment initiation among primary care patients, researchers analyzed data from a national sample of Veterans Health Administration primary care patients who screened positively for PTSD (n = 21,427). Study participants were assessed for PTSD diagnosis and treatment initiation on the day of screening and approximately 7 days, 12 weeks, 6 months and 1 year after screening positively. Screening setting was categorized as primary care only, same-day primary care–mental health integration or same-day specialty mental health care.

NAPHS publishes 2016 membership directory

October 6, 2015
The National Association of Psychiatric Health Systems recently published its 2016 membership directory, a referral resource of information on behavioral health care…
FDA News

FDA approves Aristada for schizophrenia

October 6, 2015
The FDA recently approved Aristada, an extended-release injection drug, to treat schizophrenia in adults, according to a press release.Aristada (aripiprazole lauroxil…
In the Journals

Pediatric survivors of human trafficking may have higher risk for self-harm, suicidal behaviors

October 5, 2015
Children and adolescents receiving posttrafficking services in the Greater Melong subregion exhibited high symptom levels of depression, anxiety and PTSD, which are…
More News Headlines »

Homocysteine and Neuropsychiatric Disease

Psychiatric Annals, September 2015, Volume 45 Issue 9
Elevated homocysteine (HCY) is a risk factor for a variety of vascular and neuropsychiatric pathologies. Although long…
More »
Psychiatry Case Consults

The Patient with Alzheimer’s Disease

No commercial support for this activity.

Alzheimer’s Disease is an irreversible, age-related neurodegenerative disorder characterized by gradual decline. This…
More »
Meeting News Coverage Video
VIDEO: Managing addiction with pharmacogenetic, immunotherapy approaches

VIDEO: Managing addiction with pharmacogenetic, immunotherapy approaches

September 12, 2015
SAN DIEGO — Thomas Kosten, MD, professor of psychiatry, neuroscience, pharmacology, and immunology, Baylor College of…
More »